Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus
Open Access
- 28 July 2022
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (8) , 936
Abstract
Systemic sclerosis and systemic lupus erythematosus represent two distinct autoimmune diseases belonging to the group of connective tissue disorders. Despite the great progress in the basic science, this progress has not been translated to the development of novel therapeutic approaches that can radically change the face of these diseases. The discovery of JAK kinases, which are tyrosine kinases coupled with cytokine receptors, may open a new chapter in the treatment of so far untreatable diseases. Small synthetic compounds that can block Janus kinases and interact directly with cytokine signalling may provide therapeutic potential in these diseases. In this review, we discuss the therapeutic potential of Jak kinases in light of the cytokine network that JAK kinases are able to interact with. We also provide the theoretical background for the rationale of blocking cytokines with specific JAK inhibitors.Keywords
Funding Information
- Medical University of Silesia Katowice, Poland
This publication has 145 references indexed in Scilit:
- Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine familyMolecular Immunology, 2012
- The interferon‐regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index scoreBritish Journal of Dermatology, 2012
- Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineagesNature Immunology, 2011
- The Pathogenesis of Systemic SclerosisAnnual Review of Pathology: Mechanisms of Disease, 2011
- The Role of Apoptosis Proteins and Complement Components in the Etiopathogenesis of Systemic Lupus ErythematosusClinics, 2010
- SOCS regulation of the JAK/STAT signalling pathwaySeminars in Cell & Developmental Biology, 2008
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- Disruption of the murine IL-4 gene blocks Th2 cytokine responsesNature, 1993
- Urinary IL-6: a marker for mesangial proliferative glomerulonephritis?Clinical and Experimental Immunology, 1991
- Immune Interferon in the Circulation of Patients with Autoimmune DiseaseNew England Journal of Medicine, 1979